Pleural effusion (or pleurisy) is an accumulation of exudate or transudate in the pleural cavity, which can lead to respiratory dysfunction and significant deterioration in the patient's general condition. The pleura, or serous membrane lining the chest cavity and surrounding the lungs, plays a key role in the mechanics of breathing. When pleural effusion occurs, there is compression of the lung on one side, which can cause pain, discomfort, and shortness of breath. Pleural effusion can be caused by various pathologies, including infectious processes, cardiovascular diseases, cancer, and others. Correct diagnosis and treatment of this condition are of paramount importance to prevent exacerbations and complications.
History of the disease and interesting historical facts
The history of pleural effusion goes back to ancient times, when physicians attempted to explain pathological conditions using the anatomy and physiology they knew. Ancient medical texts such as the writings of Hippocrates describe symptoms similar to pleurisy, but the concept of pleural effusion as a distinct medical entity evolved over time. In the Middle Ages, particularly during the plague, pleurisy and pleural effusion were discussed as consequences of lung disease and infection. In the 19th century, with the development of auscultation and radiological diagnostics, more precise methods for examining the pleural cavity became available. Research in the late 19th and early 20th centuries, including the work of scientists such as Louis Post and Ruben Dubois, helped advance our understanding of the formation and treatment of pleural effusion.
Epidemiology
Pleural effusion is a common clinical condition that may be caused by a variety of diseases, including infections, tumors, and cardiovascular pathologies. According to the World Health Organization (WHO), the prevalence of pleural effusion varies greatly depending on the region and population. Approximately 10% of all hospitalized patients have signs of pleural effusion, making it one of the most common reasons for visiting a physician. Pleural effusion is most common in patients with pneumonia, heart failure, and malignancy. According to recent studies, among patients with pleurisy, some form of malignancy is observed in more than 30% cases.
Genetic predisposition to this disease
Studies of genetic predisposition to pleural effusion have shown that some genetic markers may be associated with an increased risk of developing these conditions. In particular, mutations in genes responsible for the regulation of inflammatory processes, as well as genes affecting the immune response, may play a role in the development of pleural effusion in predisposed individuals. For example, studies conducted in 2021 showed a relationship between polymorphisms in the IL-6 and TNF-α genes and the frequency of pleuropneumonia accompanied by the formation of effusion. Despite the indicated correlations, it is necessary to remember the multifactorial nature of this condition, including both genetic and exogenous factors.
Risk factors for the development of this disease
A number of factors may predispose to the development of pleural effusion and these can be divided into physical and chemical. The main risk factors include:
- Infectious processes, including bacterial, viral and fungal infections.
- Malignant neoplasms and metastases, especially of the lungs and chest wall.
- Cardiovascular diseases such as heart failure.
- Chronic lung diseases, such as chronic obstructive pulmonary disease (COPD).
- Autoimmune diseases such as lupus and rheumatoid arthritis.
- Chest injuries including rib fractures and penetrating wounds.
In addition to the above reasons, occupational risk is an important aspect. Workers exposed to asbestos or other chemicals have an increased risk of developing pleural effusion.
Diagnosis of this disease
Diagnosis of pleural effusion involves several key steps, starting with a clinical examination and ending with specialized research methods. The main symptoms of the condition may include:
- Shortness of breath that occurs during physical exertion or at rest.
- Chest pain that may get worse with deep breathing or coughing.
- Cough not associated with respiratory infections.
- General malaise and decreased performance.
The necessary laboratory tests include blood tests, including biochemical parameters, and analysis of pleural fluid obtained by thoracentesis. Radiological examinations, such as chest radiography and computed tomography, allow visualization of the pleural cavities and assessment of the volume of effusion. Other diagnostics may include ultrasound examination to assess the characteristics of the pleural effusion. Differential diagnosis includes the isolation of pleural effusion based on the etiology: infectious, inflammatory, or non-infectious.
Treatment
Treatment of pleural effusion depends on the cause of its occurrence and may include both conservative and surgical methods. In general, the approach to therapy includes:
- General treatment is aimed at eliminating the underlying etiology: antibiotics for infections, diuretics for cardiovascular diseases.
- Pharmacological treatment may include anti-inflammatory drugs and corticosteroids to reduce inflammation.
- Surgical treatment involves drainage of the pleural cavity in cases of significant and life-threatening effusion.
- Other treatments may include chemotherapy or radiation therapy in cases involving malignancy.
In addition, it is important to carry out individualized therapy depending on the patient's condition and the presence of concomitant diseases.
List of medications used to treat this disease
Medicines used to treat pleural effusion include:
- Antibacterial drugs such as penicillin, cephalosporins and macrolides to treat infections.
- Anti-inflammatory drugs, including nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids.
- Diuretics that help reduce the volume of effusion in cases of heart failure.
- Drainage systems and analgesic drugs to reduce pain.
- Chemotherapeutic agents for the treatment of tumor processes, such as cisplatin and doxorubicin.
The effectiveness of treatment depends on timely and correct diagnosis, as well as on the etiology of pleural effusion.
Disease monitoring
Monitoring of pleural effusion includes regular control examinations to assess the dynamics of the condition and the possibility of complications. The main control stages are:
- Regular assessments of respiratory function, including spirometry.
- Repeated radiographic studies to visualize the pleural cavity.
- Laboratory tests, including analysis of pleural fluid for infection or malignant cells.
The prognosis depends on the underlying disease that caused the pleural effusion and the success and timeliness of treatment. Complications may include recurrence of effusion, development of pleural infection (pleurisy), and deterioration of respiratory function.
Age-related features of the disease
Pleural effusion may occur in any age group, but its nature and involvement in pathological processes may vary. In children, pleural effusion is often a consequence of pneumonia or trauma. In adults, infectious and oncological causes are most common. In the elderly, an important aspect is the presence of cardiovascular diseases and concomitant comorbidities, which can aggravate the course of pleural effusion and its consequences. Monitoring and early diagnosis in elderly patients are critical for successful treatment.
Questions and Answers
- What is pleural effusion? Pleural effusion is a buildup of fluid in the pleural space that can cause difficulty breathing and chest pain.
- What are the main causes of pleural effusion? Underlying causes include infections (pneumonia), cardiovascular disease, malignancy, and chest trauma.
- How is pleural effusion diagnosed? Diagnosis includes clinical examination, chest x-ray, pleural fluid analysis, and other radiological methods.
- How is pleural effusion treated? Treatment depends on the cause and may include antibiotics, anti-inflammatory drugs, diuretics, and, if necessary, surgical drainage.
- What is the prognosis for pleural effusion? Prognosis varies depending on the cause and timeliness of treatment; many patients have a good prognosis with proper treatment.
